Evidence map›Paper›PMID 38736328›Full record

ArticleImmunology2024

Human CD4

Dana C Baiu, Akshat Sharma, Jennifer L Schehr, Jayati Basu, Kelsey A Smith, Makoto Ohashi, Eric C Johannsen, Shannon C Kenney, Jenny E Gumperz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Human CD4Frontiers in immunology · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dana C BaiuDepartment of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Akshat SharmaDepartment of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Jennifer L SchehrCarbone Comprehensive Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Jayati BasuLerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kelsey A SmithDepartment of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Makoto OhashiDepartment of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Eric C JohannsenDepartment of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Shannon C KenneyDepartment of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Jenny E GumperzDepartment of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.ORCID 0000-0003-1852-2192

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Role of EBV Lytic Infection in Viral TumorigenesisR01CA229673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KENNEY, SHANNON CELESTE · 2019 to 2023
$2.5M
Role of Epstein-Barr virus LMP2A protein in maintaining oncogenic IgM signaling in EBV+ B cell lymphomasU01CA275247 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ERIC C JOHANNSEN · 2022 to 2026
$2.2M
Mechanisms of iNKT cell anti-viral adjuvancyR01AI136500 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GUMPERZ, JENNY E. · 2018 to 2022
$1.9M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA229673NCI NIH HHS U01 CA275247NIAID NIH HHS R01 AI136500NIH HHS P30CA014520NIH HHS R01 AI136500NIH HHS R01CA229673NIH HHS U01 CA275247
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells are a conserved population of innate T lymphocytes that are uniquely suitable as off-the-shelf cellular immunotherapies due to their lack of alloreactivity. Two major subpopulations of human iNKT cells have been delineated, a CD4

Indexed as

Antigens, CD1dEpstein-Barr Virus InfectionsHerpesvirus 4, HumanImmunotherapy, AdoptiveLymphoma, B-CellNatural Killer T-CellsAnimalsCell Line, TumorHumansMiceMice, Inbred NODMice, SCIDXenograft Model Antitumor AssaysAntigens, CD1dCD1D protein, humanadjuvancyCD1dEBViNKT cellslymphomatumour immunotherapy

Identifiers

PMID38736328
PMCPMC11223969

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.